Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer
- 1 June 1978
- Vol. 41 (6) , 2121-2130
- https://doi.org/10.1002/1097-0142(197806)41:6<2121::aid-cncr2820410608>3.0.co;2-v
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- Serum Alpha Fetoprotein and Human Chorionic Gonadotropin in the Diagnosis and Management of Nonseminomatous Germ-Cell Testicular CancerNew England Journal of Medicine, 1976
- The effect of measuring error on the results of therapeutic trials in advanced cancerCancer, 1976
- Measurement of urinary cea-like substance.An aid in management of patients with bladder carcinomaCancer, 1975
- The chemotherapy of urologic cancerCancer, 1975
- Preliminary Evaluation of Urinary Polyamines in the Diagnosis of Genitourinary Tract MalignancyJournal of Urology, 1975
- Urinary polyamine levels in human cancerCancer, 1975
- Carcinoembryonic‐like antigen in the urine of patients with carcinoma of the bladder and normal controlsJournal of Surgical Oncology, 1974
- The Enhanced Therapeutic Effect of cis-Platinum (II) Diamminodichloride against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-Dioxopiperazine-1-yl)propane or Several other Antitumor AgentsChemotherapy, 1973
- Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum CompoundsNature, 1972